Correlation between plasma glucose and hemoglobin A1c in HIV-infected individuals receiving zidovudine and non-zidovudine containing antiretroviral therapy regimens.

Thanyalak Saetang Chutintorn Sriphrapradang Angsana Phuphuakrat Somnuek Sungkanuparph

Published in: HIV research & clinical practice (2020)

HbA1c underestimates glycemia in HIV-infected individuals receiving AZT containing regimens. Factors associated with decreased HbA1c levels in HIV-infected individuals included decreased hematocrit and increased MCV. In HIV-infected individuals receiving AZT, using HbA1c for diabetes diagnosis or glycemia monitoring should be cautiously interpreted.

Keyphrases

hiv infected
antiretroviral therapy
human immunodeficiency virus
hiv positive
hiv infected patients
hiv aids
type diabetes
cardiovascular disease
adipose tissue
weight loss
hepatitis c virus